logo

For the Inventor, By the Inventor

Pearl River, NY, United States of America

William V Curran

This inventor holds 33 USPTO granted patents, plus 1 CIPO patent, primarily in Antibiotic Compositions. Top assignees: American Cyanamid Company, Biosource Pharm, Inc., Micrologix Biotech Inc.. Active years: 1976-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William V Curran. Retrieved from https://idiyas.com/inventor/william-v-curran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 84.8

 

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Pear River, NY (US) (2013)
  • Pearl River, NY (US) (1976 - 2014)

Company Filing History:

goldMedal24 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal5 out of 7 
 
Biosource Pharm, Inc.
 patents
bronzeMedal3 out of 11 
 
Micrologix Biotech Inc.
 patents
4. 2 out of 59 
 
Cubist Pharmaceuticals, Incorporated
 patents
5. 1 out of 1 
 
Biowest Therapeutics Inc.
 patent
where one patent can have more than one assignee

Years Active: 1976-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Antibiotic Compositions
Peptide Antibiotics
Gram Negative Infections
Lipopeptide Antibiotics
Beta-Lactamase Inhibitors
Cephalosporanic Acids
Thiadiazole Derivatives
Carbapenems
Sulfonamide Derivatives
Azetidinones
Antimicrobial Agents
Penicillin Derivatives
33 patents (USPTO):Explore Patents
1. 8906866 - Antibiotic compositions for the treatment of gram negative infections (2014-12-09),
2. 8889826 - Peptide antibiotics and methods for making same (2014-11-18),
3. 8415307 - Antibiotic compositions for the treatment of gram negative infections (2013-04-09),
4. 7868135 - Compositions of lipopeptide antibiotic derivatives and methods of use thereof (2011-01-11),
5. 6767718 - Lipodepsipeptide antibiotics and methods of preparation (2004-07-27),
6. 6750199 - Antimicrobial sulfonamide derivatives of lipopeptide antibiotics (2004-06-15),
7. 6737403 - Derivatives of laspartomycin and preparation and use thereof (2004-05-18),
8. 6613889 - Method for preparing salts of polyene macrolide esters (2003-09-02),
9. 6511962 - Derivatives of laspartomycin and preparation and use thereof (2003-01-28),
10. 5700930 - 4-substituted azetidinones as precursors to 2-substituted-3-carboxy (1997-12-23),
11. 5656753 - 4-substituted azetidinones as precursors to 2-substituted-3-carboxy (1997-08-12),
12. 5480987 - 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of (1996-01-02),
13. 5371215 - 4-substituted azetidinones as precursors to 2-substituted-3-carboxy (1994-12-06),
14. 5369102 - 2-substituted alkyl-3-carboxy carbopenems as antibiotics and a method of (1994-11-29),
15. 5189158 - 4-substituted azetidinones as precursors to 2-substituted-3-carboxy (1993-02-23),

Title: **William V Curran: A Pioneer in Antibiotic Innovation**

Introduction

William V Curran is an esteemed inventor based in Pearl River, NY, recognized for his significant contributions to the field of antibiotic development. With a remarkable portfolio of 33 patents to his name, Curran has focused on advancing pharmaceutical compositions that combat gram-negative infections.

Latest Patents

Curran's latest innovations include groundbreaking patents for antibiotic compositions aimed at treating gram-negative infections. One notable patent introduces novel compounds derived from polymyxin, such as polymyxin A. These innovative compounds exhibit superior antibacterial properties against a variety of gram-negative bacteria while minimizing toxicity compared to traditional polymyxins. Additionally, he has developed methods for preparing these antibacterial compounds.

Another recent patent highlights the creation of novel peptide antibiotics and the methodologies for their production. These peptides can be derived from naturally occurring peptides, including colistin, polymyxin A, and others. The pharmaceutical compositions resulting from these developments show promising potential in combating bacterial infections.

Career Highlights

Throughout his career, Curran has worked with esteemed organizations, including American Cyanamid Company and Biosource Pharm, Inc. His research and developments have consistently aimed at providing solutions to pressing medical challenges, particularly in the realm of antibiotic resistance and infection treatment.

Collaborations

Curran has collaborated with notable peers in his field, including Richard A Leese and Donald B Borders. These partnerships have further enriched his innovations and contributed to the success of his research projects.

Conclusion

William V Curran continues to be a prominent figure in the development of antibiotic therapies, leading innovative advancements through his patent portfolio. His contributions are vital in addressing the growing concerns surrounding antibiotic-resistant bacteria, affirming his status as a key inventor in the pharmaceutical landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…